About Daniel Lim

Daniel Lim is a partner in Kirkland & Ellis International LLP’s IP litigation practice in London, where he focuses on high-stakes life sciences patent litigation – particularly with regard to diagnostics, precision medicine, cell and gene therapy, and the pharmaceutical industry. His case experience covers a broad range of technical fields (including oncology, molecular biology, diagnostics, antibody engineering and biostatistics) and often involves issues at the cutting edge of the law – notably in relation to second medical-use patents. Daniel is widely sought-after for commentary on life sciences and IP topics. He is active as a member of International Association for the Protection of Intellectual Property (AIPPI) and the European Patent Lawyers Association (EPLAW), including as vice-chair of AIPPI’s standing committee on biotechnology.